These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9248783)

  • 1. Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol.
    Hernández RM; Gascón AR; Calvo MB; Caramella C; Conte U; Domínguez-Gil A; Pedraz JL
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):145-50. PubMed ID: 9248783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers.
    Chik Z; Basu RC; Pendek R; Lee TC; Mohamed Z
    Int J Clin Pharmacol Ther; 2009 Jun; 47(6):413-8. PubMed ID: 19473604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigation of the pharmacokinetics of pulsatile-release salbutamol sulfate with pH-sensitive ion exchange resin as the carriers in beagle dogs.
    Liu H; Sun T; Yu F; Zhao X; Guo H; Pan W
    Chem Pharm Bull (Tokyo); 2007 Mar; 55(3):480-1. PubMed ID: 17329898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of bioequivalence between ventasol syrup and ventolin syrup in humans and in dogs.
    Simon OR; Chang C
    West Indian Med J; 1994 Jun; 43(2):39-42. PubMed ID: 7941494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of salbutamol enantiomers in human plasma and urine by chiral high-performance liquid chromatography.
    Boulton DW; Fawcett JP
    J Chromatogr B Biomed Appl; 1995 Oct; 672(1):103-9. PubMed ID: 8590921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuterol extended-release products: effect of food on the pharmacokinetics of single oral doses of Volmax and Proventil Repetabs in healthy male volunteers.
    Hussey EK; Donn KH; Powell JR; Lahey AP; Pakes GE
    J Clin Pharmacol; 1991 Jun; 31(6):561-4. PubMed ID: 1880222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of a controlled-release albuterol formulation for twice-daily use.
    Sykes RS; Reese ME; Meyer MC; Chubb JM
    Biopharm Drug Dispos; 1988; 9(6):551-6. PubMed ID: 3228576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability and pharmacokinetics of three formulations of albuterol.
    Powell ML; Weisberger M; Gural R; Chung M; Patrick JE; Radwanski E; Symchowicz SS
    J Pharm Sci; 1985 Feb; 74(2):217-9. PubMed ID: 3989697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective disposition of salbutamol in man following oral and intravenous administration.
    Boulton DW; Fawcett JP
    Br J Clin Pharmacol; 1996 Jan; 41(1):35-40. PubMed ID: 8824691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
    Hussey EK; Donn KH; Powell JR
    Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of levosalbutamol: what are the clinical implications?
    Boulton DW; Fawcett JP
    Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers.
    Schmekel B; Rydberg I; Norlander B; Sjöswärd KN; Ahlner J; Andersson RG
    Eur Respir J; 1999 Jun; 13(6):1230-5. PubMed ID: 10445595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superhydrophobic Surface for Enhancing the Bioavailability of Salbutamol Sulfate from Cross-Linked Microspheres: Formulation, Characterization, and in vivo Evaluation.
    Gaber D; Abdoun S; Alfuraihy A; Altasan B; Alsubaiyel A
    Drug Des Devel Ther; 2021; 15():2869-2884. PubMed ID: 34239296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.
    Du XL; Zhu Z; Fu Q; Li DK; Xu WB
    Acta Pharmacol Sin; 2002 Jul; 23(7):663-6. PubMed ID: 12100764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the piecewise rational quadratic interpolant to the AUC calculation in the bioavailability study.
    Akhter KP; Ahmad M; Khan SA; Ramzan M; Shafi I; Muryam B; Javed Z; Murtaza G
    Acta Pol Pharm; 2012; 69(1):81-5. PubMed ID: 22574510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis.
    Demnati R; Michoud MC; Jeanneret-Grosjean A; Ong H; Du Souich P
    Br J Clin Pharmacol; 1995 Oct; 40(4):319-24. PubMed ID: 8554933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol.
    Fowler SJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Apr; 51(4):359-62. PubMed ID: 11318774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects.
    Bethke TD; Giessmann T; Westphal K; Weinbrenner A; Hauns B; Hauschke D; David M; Lahu G; Zech K; Hermann R; Siegmund W
    Int J Clin Pharmacol Ther; 2006 Nov; 44(11):572-9. PubMed ID: 17176624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free system.
    Harrison LI; Cline A; Wells TM; Jacobson JP; Cooper KM; Chang SF; Nelson JR; Ekholm BP; Morganroth J
    Ther Drug Monit; 1996 Jun; 18(3):240-4. PubMed ID: 8738762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Eur J Clin Pharmacol; 1997; 53(1):47-9. PubMed ID: 9349929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.